These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37877680)

  • 1. Tuberculosis Variant with Rifampin Resistance Undetectable by Xpert MTB/RIF, Botswana.
    Modongo C; Barilar I; Wang Q; Molefi T; Makhondo T; Niemann S; Shin SS
    Emerg Infect Dis; 2023 Nov; 29(11):2403-2406. PubMed ID: 37877680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid Detection of Extensive Drug Resistance by Xpert MTB/XDR Optimizes Therapeutic Decision-Making in Rifampin-Resistant Tuberculosis Patients.
    Chen X; Li R; Ge S; Li Y; Cai C; Weng T; Zhang Y; Jiang J; Feng Z; Chen Y; Zhang Y; Ma J; Persing DH; Chen J; Tang YW; Sun F; Zhang W
    J Clin Microbiol; 2023 Jun; 61(6):e0183222. PubMed ID: 37249422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia.
    Ershova JV; Volchenkov GV; Somova TR; Kuznetsova TA; Kaunetis NV; Kaminski D; Demikhova OV; Chernousova LN; Vasilyeva IA; Kerr EM; Cegielski JP; Kurbatova EV
    BMC Infect Dis; 2020 Jul; 20(1):543. PubMed ID: 32711457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues.
    Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M
    Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.
    Kohli M; Schiller I; Dendukuri N; Yao M; Dheda K; Denkinger CM; Schumacher SG; Steingart KR
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD012768. PubMed ID: 33448348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study.
    Boehme CC; Nicol MP; Nabeta P; Michael JS; Gotuzzo E; Tahirli R; Gler MT; Blakemore R; Worodria W; Gray C; Huang L; Caceres T; Mehdiyev R; Raymond L; Whitelaw A; Sagadevan K; Alexander H; Albert H; Cobelens F; Cox H; Alland D; Perkins MD
    Lancet; 2011 Apr; 377(9776):1495-505. PubMed ID: 21507477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application value of Xpert MTB/RIF in diagnosis of spinal tuberculosis and detection of rifampin resistance].
    Jin YH; Shi SY; Zheng Q; Shen J; Ying XZ; Wang YF
    Zhongguo Gu Shang; 2017 Sep; 30(9):787-791. PubMed ID: 29455477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Accuracy of Xpert
    Feng JN; Gao L; Sun YX; Yang JC; Deng SW; Sun F; Zhan SY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):320-326. PubMed ID: 33879905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of GeneXpert
    Habous M; E Elimam MA; Kumar R; L Deesi ZA
    Int J Mycobacteriol; 2019; 8(2):132-137. PubMed ID: 31210154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis in Southwest China.
    Li TX; Wang J; Yang YS; Wang PS; Zhou G; Liao CY; Zhang HZ; Luo M; Zeng XG; Yang GQ; Yang LJ; Chen YK
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011403. PubMed ID: 37363913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Xpert® MTB/RIF assay in routine diagnosis of pulmonary tuberculosis: A multicentre study in Lithuania.
    Pimkina E; Zablockis R; Nikolayevskyy V; Danila E; Davidaviciene E
    Respir Med; 2015 Nov; 109(11):1484-9. PubMed ID: 26403251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study.
    van Kampen SC; Susanto NH; Simon S; Astiti SD; Chandra R; Burhan E; Farid MN; Chittenden K; Mustikawati DE; Alisjahbana B
    PLoS One; 2015; 10(6):e0123536. PubMed ID: 26075722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
    Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
    PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.
    Zetola NM; Shin SS; Tumedi KA; Moeti K; Ncube R; Nicol M; Collman RG; Klausner JD; Modongo C
    J Clin Microbiol; 2014 Jul; 52(7):2422-9. PubMed ID: 24789181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How has the Zimbabwe mycobacterial culture and drug sensitivity testing system among re-treatment tuberculosis patients functioned during the scale-up of the Xpert MTB/RIF assay?
    Timire C; Takarinda KC; Harries AD; Mutunzi H; Manyame-Murwira B; Kumar AMV; Sandy C
    Trans R Soc Trop Med Hyg; 2018 Jun; 112(6):285-293. PubMed ID: 29992299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Evaluation of GeneXpert MTB/RIF Ultra and GeneXpert MTB/RIF for Detecting Tuberculosis and Identifying Rifampicin Resistance in Pars Plana Vitrectomy Samples of Patients with Ocular Tuberculosis.
    Sharma K; Sharma M; Ayyadurai N; Dogra M; Sharma A; Gupta V; Singh R; Gupta A
    Ocul Immunol Inflamm; 2023 Jul; 31(5):914-920. PubMed ID: 35442853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the bacillary load on the accuracy of rifampicin resistance results by Xpert
    Ocheretina O; Brandao AP; Pang Y; Rodrigues C; Banu S; Ssengooba W; Dolinger DL; Salfinger M; Ngabonziza JCS; Köser CU
    Int J Tuberc Lung Dis; 2021 Nov; 25(11):881-885. PubMed ID: 34686228
    [No Abstract]   [Full Text] [Related]  

  • 18. Case report of a false positive result of the Xpert
    Claessens J; Mathys V; Derdelinckx I; Saegeman V
    Acta Clin Belg; 2017 Jun; 72(3):195-197. PubMed ID: 26400761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of false-positive rifampicin resistance on the Xpert MTB/RIF.
    Cayci YT; Bilgin K; Coban AY; Birinci A; Durupınar B
    Mem Inst Oswaldo Cruz; 2017 Nov; 112(11):756-759. PubMed ID: 29091135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study.
    Soeroto AY; Lestari BW; Santoso P; Chaidir L; Andriyoko B; Alisjahbana B; van Crevel R; Hill PC
    PLoS One; 2019; 14(2):e0213017. PubMed ID: 30818352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.